The source appears to be about XRP regulation, but most of its weight is placed on promoting the Pepeto presale. It says XRP was classified as a digital commodity on March 17 by the SEC and CFTC, describing that move as the end of a five-year legal fight. It also states that spot XRP ETFs have gathered $1.44 billion in cumulative inflows, with a final approval deadline set for March 27.
XRP figures are used mainly as a comparison point
According to the article, XRP was trading near $1.45 on March 23, down 60% from its January high of $3.65. It adds that seven spot XRP ETFs had already pulled in $1.44 billion, with 84% of that money coming from retail investors rather than institutions. The piece says analyst targets sit in the $3.00 to $4.00 range by year-end if institutional capital enters after March 27, framing XRP as a slower 2x to 3x trade from current levels.
Pepeto is presented as the higher-upside alternative
The article then shifts hard into Pepeto. It claims the presale has raised more than $8 million, with the token priced at $0.000000186 and offering 194% APY staking. It also promotes PepetoSwap as a zero-fee trading venue and says its cross-chain bridge moves tokens at no cost. The platform’s risk scanner is described as a tool that can detect honeypot functions, hidden approval drains, and fake liquidity locks.
The source also says the contracts were audited by SolidProof, that a former Binance expert is part of the team, and that a cofounder tied to the original Pepe coin is involved. It repeatedly links Pepeto to “100x” return math and treats a future Binance listing as the event that could unlock that move.
The line between reporting and promotion is thin
There are real news elements in the piece: the stated commodity classification, ETF flow totals, and XRP price references. Even so, large sections read like direct marketing copy for a token presale, including calls to visit the official website and buy before listing. That makes the article less useful as straight policy coverage and more relevant as an example of how regulatory headlines can be used to funnel attention toward speculative presale narratives.